Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1176574

Cover Image

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1176574

Global Medical Gas Analyzers Market - 2023-2030

PUBLISHED:
PAGES: 200 Pages
DELIVERY TIME: 2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4350
PDF & Excel (Multiple User License)
USD 4850
PDF & Excel (Enterprise License)
USD 7850

Add to Cart

Market Overview

Medical Gas Analyzers Market size was valued at US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing at a CAGR of 3.5% during the forecast period (2023-2030).

Medical gas analyzers are designed particularly for medical oxygen handled by gas suppliers, hospitals and the aviation industry. They are used to sample and measure gases of medical importance, such as anesthesia and respiratory monitoring and detecting trace gases for diagnostic purposes.

Global Medical Gas Analyzers Market -Market Dynamics

The global medical gas analyzers market is driven by technological advancements, the growing adoption of medical gas analyzers in hospitals, urbanization, rising pollution, sedentary lifestyle, pandemics, the aging population and the rise of chronic diseases (respiratory and diabetes).

Increasing advantages of medical gas analyzers drive market growth

The rising geriatric population and increasing chronic disease drive the medical gas analyzers market in the forecast period. Medical gas analyzers are essential in monitoring and analyzing gases used in hospitals and healthcare facilities. The market players are providing products with advanced features to treat patients. For instance, Helix Private Limited offers an Oxygen flow and purity monitor in real time. The device was designed and developed to continuously monitor critical parameters of oxygen: pressure and oxygen purity. This device is designed and developed to continuously monitor critical parameters of oxygen, such as Pressure, Oxygen purity/concentration, and current flow/consumption. This device is best utilized in oxygen concentrator/generator systems, where continuous monitoring of these crucial parameters is very important for the medical facility.

In addition, Ntron design and manufactures gas measuring systems for medical-use oxygen, which are crucial in monitoring and analyzing gases used in hospitals and healthcare facilities. The company offers dependable and accurate measurements of oxygen purity, and trace levels of carbon dioxide, carbon monoxide, and moisture are essential in a patient-focused setting. Medical-use oxygen is used for resuscitation and inhalation therapy and medical conditions such as COPD, cyanosis, shock, trauma, severe hemorrhage, carbon monoxide poisoning, cardiovascular and respiratory arrest, resuscitation, and life support. For patient safety, Ntron's medical gases monitors and analyzers are developed to measure the quality of medical-use oxygen, carbon monoxide, and carbon dioxide channeled through the hospital or facility medical gas piping network or anywhere a medical gas outlet is available.

The lack of awareness in clinicians will hamper the growth of the market

However, there needs to be more awareness among clinicians regarding the medico-legal aspect involved with the medical gas pipeline systems. It is a highly technical field; hence, in-depth knowledge is a must to ensure the system's safety. These factors are limiting the market growth.

COVID-19 Impact Analysis

The appearance of COVID-19 positively impacted the global medical gas analyzers market. According to Medical Gas Professional Healthcare Organization (MGPHO), all ventilators do not use oxygen & medical air. For this reason, getting a complete list of the respiratory equipment facilities used to combat a surge in COVID-19 patients is very important.

There are a few ways that the capacity of medical gas systems can be increased or supplemented to deal with the additional ventilator usage required by patients with COVID-19, including increasing existing system capacity, supplementing existing systems to deal with a surge in usage, back feed areas of the hospital as needed to accommodate overconsumption, and installing separate supply systems for temporary surge areas.

In addition, the increased use of oxygen is due to the use of ventilators to treat patients with the COVID-19 virus. It has been reported that these infected patients on ventilators have been using 80- 100% oxygen due to the virus affecting the respiratory system. So, the oxygen systems are the primary focus of the information provided. Still, medical air may also become a concern as patients are weaned off ventilators, which would increase the demand for medical air-resulting in the increasing demand for medical gas analyzers in the pandemic.

Global Medical Gas Analyzers Market - Segment Analysis

The multiple gas analyzer segment is expected to grow at the fastest CAGR during the forecast period (2022-2029).

The multiple gas analyzer segment accounts for the largest market share. Inert gases are constantly available for those who work in hospitals, medical institutions, research clinics, and cryogenics. Nitrogen, oxygen, argon, helium, and carbon dioxide are frequently used in these industries to operate MRI equipment, generate extremely low temperatures, preserve pH samples, and freeze tissues like cancer cells. To retain the best sampling data and advance in the area, professionals in this industry must be able to monitor the gases in an environmental atmosphere precisely. Multiple gas detection will assure users that their research data is being measured and gathered precisely.

Because various inert gases are used in incubation and life science conditions, technicians need a thorough analysis of carbon dioxide (CO2) and oxygen (O2) in research operations. Measuring these inert gases is essential for pH management since carbon dioxide and oxygen are both essential for cell growth and embryo development. Researchers can maintain the precise conditions needed for culturing 20% O2 and 5-7% CO2 by using the multi-gas sampling data logger from CO2Meter.

Geographical Analysis

North America region holds the largest market share of the global medical gas analyzers market

North America dominates the market for medical gas analyzers and is anticipated to show a parallel trend over the forecast period. The market is boosted by factors such as the growing incidence of chronic disease, high prevalence of smoking and rising pollution levels, increasing geriatric population, changes in lifestyles and eating habits, and easy availability of products in the North American region.

According to American Hospital Association, an increasing number of Americans are coping with chronic health conditions and diseases that are ongoing and generally not curable. Currently, nearly half of Americans suffer from at least one chronic illness, such as hypertension, heart disease and arthritis. Over the past 15 years, the number of people with diabetes has doubled. The growing population with chronic diseases is driving the medical gas analyzers market in the region.

The market players are offering the products in the North American region. For instance, City's MediceL (MOX) sensors include oxygen and a range of other gas sensors designed specifically for respiratory and anesthesia applications.

Global Medical Gas Analyzers Market - Competitive Landscape

The medical gas analyzers market is a moderately competitive presence of local and global companies. Some of the key players contributing to the market's growth are Air Products and Chemicals, Inc., Air Liquide, Dragerwerk AG & Co. KGaA, MEECO Inc., Matheson Tri-Gas, Novair Medical, Roscid Technologies, The Linde Group, Praxair, Inc., and Fluke Corporation., among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, contributing to the growth of the medical gas analyzers market globally.

For instance,

In May 2020, Roche announced the CE mark availability of Roche v-TAC. This new digital diagnostic solution permits clinicians to obtain results for arterial blood gas values from patients with respiratory or metabolic abnormalities via a simpler, less invasive venous puncture through a digital algorithm.

Air Liquide

Overview:

Air Liquide is a multinational company founded in 1902 and headquartered in France. Air Liquide Healthcare provides BeaconMedaes medical gas pipeline products. With medical gas monitoring equipment, alarms, outlets, gas control panels, valves and manifolds, ensure the proper instruction is provided to the right person at the right time.

Product Portfolio:

TotalAlert Infinity: This medical gas notification system is a monitoring device that offers customized instructions, taking the confusion out of an emergency. The alarm panels permit users to set up customized instructions for individual alarm signals to occur on the screen when the signal is in alarm.

The global medical gas analyzers market report would provide access to approximately 60+ market data tables, 60+ figures, and in the range of 200 (approximate) pages.

Product Code: DMMD1125

Table of Contents

1. Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing number of hospitals and healthcare centers
      • 4.1.1.2. Rise in number of medical gas-based therapies
    • 4.1.2. Restraints:
      • 4.1.2.1. Lack of awareness of medical gas analyzers
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Single Gas Analyzer*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Multiple Gas Analyzer

8. By Modality Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
    • 8.1.2. Market Attractiveness Index, By Modality Type
  • 8.2. Handheld Analyzer*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Portable Analyzer
  • 8.4. Benchtop Analyzer

9. By Technology

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 9.1.2. Market Attractiveness Index, By Technology
  • 9.2. Electrochemical*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Infrared
  • 9.4. Optical

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Ambulatory Surgical Centers
  • 10.4. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Type Benchmarking

13. Company Profiles

  • 13.1. Air Products and Chemicals, Inc.*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Air Liquide
  • 13.3. Dragerwerk AG & Co. KGaA
  • 13.4. MEECO Inc.
  • 13.5. Matheson Tri-Gas
  • 13.6. Novair Medical
  • 13.7. Roscid Technologies
  • 13.8. The Linde Group
  • 13.9. Praxair, Inc.
  • 13.10. Fluke Corporation

LIST NOT EXHAUSTIVE

14. Global Medical Gas Analyzers Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!